Lakefront Biotherapeutics American (LKFT) Stock Price, News & Analysis
What Changed
Price Move History
- Daily moves over 5%
- 1 87 sessions, May 8, 2026 to September 11, 2026
- Largest daily move
- +6.8% close of August 11, 2026
Company Description
Lakefront Biotherapeutics American (NASDAQ: LKFT) is classified in the biotechnology industry within the Healthcare sector and carries a market capitalization of $1.8B.
LKFT has declined 6.7% over the past month. The last closing price was $26.81.
This page collects what Stock Titan holds for LKFT, including price data, latest news, SEC filings, insider trading activity, financial highlights, upcoming events, and short interest trends.
Stock Performance
Lakefront Biotherapeutics American (LKFT) closed at $26.81 on September 11, 2026. Over the past month, the price has lost 6.7%.
LKFT Metrics & Rankings
Price returns through September 11, 2026. Month-to-date and YTD include the first trading day. Ranking links may use different dates.
Latest News
Lakefront Biotherapeutics American has 2 recent news articles. Of the recent coverage, 0 articles coincided with positive price movement and 2 with negative movement. Key topics include acquisition. View all LKFT news →
SEC Filings
Lakefront Biotherapeutics American has filed 5 recent SEC filings, including 5 Form 6-K. The most recent filing was submitted on September 8, 2026. SEC filings provide transparency into a company's financial condition, material events, and regulatory compliance. View all LKFT SEC filings →
Financial Highlights
Upcoming Events
Short Interest History
Short interest in Lakefront Biotherapeutics American (LKFT) currently stands at 3.0 million shares, up 17.9% from the previous reporting period, representing 6.1% of the float. Since May 2026, short interest has increased by 85.5%. With 10.2 days to cover, it would take significant time for short sellers to close their positions based on average trading volume.
Days to Cover History
Days to cover for Lakefront Biotherapeutics American (LKFT) currently stands at 10.2 days, down 27.6% from the previous period. This elevated days-to-cover ratio indicates it would take over two weeks of average trading volume for short sellers to exit their positions, suggesting potential for a short squeeze if positive news emerges. The ratio has shown significant volatility over the period, ranging from 9.4 to 16.1 days.
LKFT Company Profile & Sector Positioning
Lakefront Biotherapeutics American (LKFT) operates in the Biotechnology industry within the broader Healthcare sector and is listed on the NASDAQ.